Global perspective of the risks of falsified and counterfeit medicines: A critical review of the literature

被引:1
|
作者
Feeney, Aonghus J. [1 ]
Goad, Jeffery A. [2 ]
Flaherty, Gerard T. [1 ]
机构
[1] Univ Galway, Sch Med, Coll Med Nursing & Hlth Sci, Galway, Ireland
[2] Chapman Univ, Sch Pharm, Irvine, CA USA
关键词
Global health; Travel health; International travel; Counterfeit drugs; Falsified medicines; MIDDLE-INCOME COUNTRIES; CROSS-SECTIONAL SURVEY; ANTIMALARIAL-DRUGS; PHARMACOPEIAL QUALITY; SUBSTANDARD MEDICINES; ANTIMICROBIAL DRUGS; SOUTHEAST-ASIA; CURRENT STATE; LAO PDR; HEALTH;
D O I
10.1016/j.tmaid.2024.102758
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The increasing prevalence of falsified and counterfeit medicines globally poses risks to international travellers. This narrative literature review examines the global challenge of falsified and counterfeit medicines, with a specific focus on risks for travellers. The aim is to provide a comprehensive understanding of this multidimensional issue, exploring potential solutions for effective intervention. Methods: A comprehensive search of databases, including PubMed, MEDLINE, and Scopus, as well as relevant reports from international organisations, was undertaken. There was a focus on extracting information pertaining to the prevalence, types, and geographical patterns of falsified and counterfeit medicines encountered by international travellers. Synthesising this information helped to identify overarching trends and patterns. This narrative review utilised a thematic analysis approach to synthesise the findings. Results: The findings revealed a diverse range of counterfeit drug categories, spanning from antibiotics to lifestyle medications, posing unique risks to travellers navigating the global pharmaceutical landscape. The review emphasises the geographical distribution of these drugs, with varying consequences for both high- and low-income nations. The inadequate formulations and inconsistent drug release arising from these practices pose severe threats to public health, especially for individuals travelling abroad. The review also highlights the significance of international collaboration in addressing this global challenge, as pharmaceutical supply chains seamlessly cross borders, necessitating a collaborative approach for effective regulation and enforcement. Conclusions: This review underscores the need for targeted research, collaborative interventions, and technological innovations to address the complexities associated with falsified and counterfeit medicines, ensuring the safety and well-being of international travellers.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] COUNTERFEIT AND FALSIFIED MEDICINES IN THE EUA LEGAL PERSPECTIVE
    Blakeney, Michael
    UNIVERSITY OF WESTERN AUSTRALIA LAW REVIEW, 2022, 49 (02): : 341 - 344
  • [2] Counterfeit and falsified medicines, alert the patient
    Guerriaud, Mathieu
    ACTUALITES PHARMACEUTIQUES, 2018, 57 (580): : 1 - 1
  • [3] Chemometrical analysis of fingerprints for the detection of counterfeit and falsified medicines
    Custers, Deborah
    Courselle, Patricia
    Apers, Sandra
    Deconinck, Eric
    REVIEWS IN ANALYTICAL CHEMISTRY, 2016, 35 (04) : 145 - 168
  • [4] Substandard and counterfeit medicines: a systematic review of the literature
    Almuzaini, Tariq
    Choonara, Imti
    Sammons, Helen
    BMJ OPEN, 2013, 3 (08):
  • [5] Digital intervention to reduce counterfeit and falsified medicines: A systematic review and future research agenda
    Islam, Iyolita
    Islam, Muhammad Nazrul
    JOURNAL OF KING SAUD UNIVERSITY-COMPUTER AND INFORMATION SCIENCES, 2022, 34 (09) : 6699 - 6718
  • [6] Combating Sale of Counterfeit and Falsified Medicines Online: A Losing Battle
    Lee, Kah Seng
    Yee, Siew Mei
    Zaidi, Syed Tabish Razi
    Patel, Rahul P.
    Yang, Quan
    Al-Worafi, Yaser Mohammad
    Ming, Long Chiau
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [7] Commentary: Combating Sale of Counterfeit and Falsified Medicines Online: A Losing Battle
    Huang, Baobin
    Xu, Mingzhe
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [8] Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
    El-Dahiyat, Faris
    Fahelelbom, Khairi M. S.
    Jairoun, Ammar Abdulrahman
    Al-Hemyari, Sabaa Saleh
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [9] Counterfeit Medicines: Problems, Risks, Possible Safeguards
    Piotrowiaki, Ralf
    Rabe, Klaus
    Mehnert, Joerg
    PHARMAZEUTISCHE INDUSTRIE, 2012, 74 (07): : 1172 - 1179
  • [10] Stemming the Global Trade in Falsified and Substandard Medicines
    Gostin, Lawrence O.
    Buckley, Gillian J.
    Kelley, Patrick W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (16): : 1693 - 1694